Intravitreal ranibizumab associated with subfoveal choroidal thinning in idiopathic disease

  • April 16, 2014

Intravitreal ranibizumab therapy was associated with thinning of the subfoveal choroid in patients treated for unilateral idiopathic subfoveal choroidal neovascularization, a study found.

The prospective study included 16 patients with unilateral idiopathic subfoveal choroidal neovascularization who underwent a single intravitreal injection of 0.5 mg ranibizumab and subsequent injections as needed.

Investigators used enhanced depth imaging optical coherence tomography to measure subfoveal choroidal thickness (SFCT). Mean patient age was 31.9 years. Visual acuity was also evaluated.
Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

More »
More »
More »
  • Meeting News Coverage
  • OSN meeting
  • WOC 2014
  • Coverage from the World Ophthalmology Congress in Tokyo.
More »
More »
  • Health Care Update
  • False claims enforcement
  • Settlement covers physician's false claims, along with the hospital where services occurred. Analysis by Alan E. Reider of Arnold & Porter LLP.
More »